60
Zhejiang Starry Pharmaceutical Co.,Ltd.
603520.SS · SHH
¥8.26 -0.48% (-¥0.04)
1M -9.29%
Market Cap ¥3.75B
P/E Ratio 178.52x
Div. Yield 0.58%
ROE 0.82%
Piotroski F-Score Moderate
4/9Valuation
30 /100
Expensive P/S 1.52x
P/E 178.52x
P/B 1.51x
Growth
55 /100
Stable Book val. growth 13.16%
Rev. growth 4.69%
FCF growth N/A
Profitability
11 /100
Weak Op. margin 1.83%
Gross margin 19.93%
FCF margin 8.78%
Quality
7 /100
Poor ROA 0.35%
ROIC 0.80%
Asset turnover 0.41x
Debt
22 /100
High Int. coverage 0.89x
Debt/Equity 1.17x
Net debt/EBITDA 10.57x
Stability
51 /100
Moderate EPS volatility 192.45%
Beta 0.49x
Profitable years 1
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre 603520.SS
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Weiyi Shen
Employees
1,905
Headquarters
Taizhou
Evenimente viitoare
29 OCT.
Earnings
Upcoming earnings report